Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Association of Psychopharmacological Medication Preference with Autistic Traits and Emotion Regulation in ADHD
1
x
$
30.00
VOL 3 No. 4 Full Issue - April 2001
1
x
$
20.00
VOL 2 No. 2 Full Issue - February 2000
1
x
$
20.00
A Comprehensive Review of Lemborexant to Treat Insomnia
1
x
$
30.00
Assessment of Anxiety in Clinical Trials with Depressed Patients
1
x
$
30.00
Theodore J. Anfinson, MD: Drug Dependence Involving Prednisone:Two Cases and a Review of the Literature
1
x
$
30.00
A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812 (Viloxazine Extended- Release) in Adolescents with ADHD (OPEN ACCESS)
1
x
$
0.00
Gender-Specific Differences in Depression and Treatment Response
1
x
$
30.00
Charles B. Nemeroff, MD, PhD: Duloxetine for the Treatment of Major Depressive Disorder
1
x
$
30.00
View Cart
Checkout
Home
antidepressant-agents-drug-interactions-liquid-chromatography-mass-spectrometry-membrane-transport-proteins-microsomes
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Desvenlafaxine and Venlafaxine Exert Minimal In Vitro Inhibition of Human Cytochrome P450 and P-Glycoprotein Activities
$
30.00
Add to cart
Details
Page load link
Go to Top
